Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Aaron Judges Comments on Mets Manager Carlos Mendoza Highlight NYC Baseball Dynamics Algonquin AQN Q1 2026 Earnings EPS 013 Beats Estimates UK Economy Defies War Concerns Surprise 03 Growth in March Arc Tx ARCT Q1 2026 Earnings Surprise EPS 095 Up Significant Geopolitical Tensions Escalate as Ukraine Strikes Russian Drone Unit Putin Vows Retaliation Wall Street Maintains Cautious Stance on Snap Inc Following Latest Earnings Report SP 500 Edges Higher as Consumer Staples and Discretionary Lead Tech Slips Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks General Motors Expands EV Lineup With New AllElectric Cadillac Vistiq Targeting 300Mile Range Puig Shares Plunge on Termination of Este Lauder Deal Talks European Stocks Rise Amid Macro Concerns SSL Q1 2026 Earnings Modest EPS Beat Amidst Operational Discipline Digimarc Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline VICR Q1 2026 Earnings EPS Surprises 1983 Above Estimates as Stock Declines Slightly IVF Q3 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 375 BBDC Q1 2026 Earnings EPS Falls Short as Stock Rises MTUS Q1 2026 Earnings EPS Surprise Drives Stock Higher Invest Green Acquisition Corporation IGAC Holds Steady Near Support Amid Quiet Trading Franklin BSP Realty Trust FBRT Holds Near Support Amid Modest Decline Perdoceo Education PRDO Slips Slightly as Shares Approach Support Zone Capitol Federal Financial Inc CFFN Edges Higher Amid Consolidation Near Support Solventum SOLV Holds Steady Near Support as Traders Eye Resistance at 8067 GAINZ Notes Hold Near Flat as Bond Market Awaits Catalyst Arvinas Inc ARVN Consolidates Near Support Amid Low Volatility Pebblebrook Hotel Trust PEB Holds Steady Near Support Whats Driving the Flat Trading PagerDuty Shares Edge Higher as Bulls Test Key Resistance at 756 Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus